UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of May 2024
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F ☒
 
Form 40-F ☐
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
99.1
 08 May 2024 - “Results of Haleon 2024 Annual General Meeting”
 
 
 
 
99.1
 
 
 
 
Haleon plc: Results of Haleon 2024 Annual General Meeting
 
8 May 2024: Haleon plc (the "Company") (LSE/NYSE: HLN) announces that the following resolutions were decided by poll vote at the Company's 2024 Annual General Meeting ("AGM") which was held today.
 
Resolutions 19, 20, 21, 22 and 23 were passed as special resolutions; all other resolutions were passed as ordinary resolutions. Full text of the resolutions is contained in the Company's Notice of AGM, which is available at www.haleon.com.
 
Haleon plc - Poll Results
 
Resolution
Votes for
For (% of shares voted)
Votes against
Against (% of shares voted)
Total votes cast (excluding withheld)
% of issued share capital voted1
Votes withheld2
1
To receive the Annual Report & Accounts
7,919,982,698
99.98
1,912,695
0.02
7,921,895,393
86.75
27,443,703
2
To approve the Directors' Remuneration Report
7,586,720,188
95.74
337,969,514
4.26
7,924,689,702
86.78
24,649,536
3
To declare a final dividend
7,925,111,048
99.98
1,306,988
0.02
7,926,418,036
86.80
22,921,018
4
To re-elect Sir Dave Lewis
7,776,694,667
98.12
148,882,400
1.88
7,925,577,067
86.79
23,760,986
5
To re-elect Brian McNamara
7,895,750,784
99.62
29,983,210
0.38
7,925,733,994
86.79
23,604,061
6
To re-elect Tobias Hestler
7,862,098,220
99.20
63,569,514
0.80
7,925,667,734
86.79
23,660,869
7
To re-elect Manvinder Singh (Vindi) Banga
7,850,438,949
99.05
75,078,917
0.95
7,925,517,866
86.79
23,816,186
8
To re-elect Marie-Anne Aymerich
7,875,097,674
99.36
50,511,000
0.64
7,925,608,674
86.79
23,729,379
9
To re-elect Tracy Clarke
7,811,967,620
98.57
113,662,811
1.43
7,925,630,431
86.79
23,707,622
10
To re-elect Dame Vivienne Cox
7,866,672,212
99.26
58,970,463
0.74
7,925,642,675
86.79
23,695,377
11
To re-elect Asmita Dubey
7,900,143,514
99.68
25,487,188
0.32
7,925,630,702
86.79
23,707,349
12
To re-elect Deirdre Mahlan
6,982,240,376
88.31
924,143,645
11.69
7,906,384,021
86.58
42,954,032
13
To re-elect David Denton
7,889,873,836
99.55
35,557,933
0.45
7,925,431,769
86.78
23,906,285
14
To re-elect Bryan Supran
7,890,428,132
99.56
35,117,662
0.44
7,925,545,794
86.79
23,791,864
15
To re-appoint KPMG LLP as auditor of the Company
7,909,270,829
99.79
16,746,573
0.21
7,926,017,402
86.79
23,320,243
16
To authorise the Audit & Risk Committee to determine the remuneration of the auditor
7,924,013,951
99.98
1,760,576
0.02
7,925,774,527
86.79
23,561,370
17
To authorise the Company to make political donations
7,860,827,630
99.42
45,956,705
0.58
7,906,784,335
86.58
42,553,903
18
To authorise the Directors to allot shares
7,674,156,770
96.83
250,966,046
3.17
7,925,122,816
86.78
24,216,236
19
General authority to disapply pre-emption rights
7,708,543,512
97.28
215,438,109
2.72
7,923,981,621
86.77
25,356,460
20
Additional authority to disapply pre-emption rights
7,612,018,804
96.06
311,981,315
3.94
7,924,000,119
86.77
25,336,232
21
To shorten the notice period for General Meetings
7,511,133,326
94.77
414,387,584
5.23
7,925,520,910
86.79
23,816,443
22
To authorise the Company to purchase its own shares
7,902,657,875
99.73
21,458,230
0.27
7,924,116,105
86.77
25,218,017
23
To authorise the Company to make off-market purchases of its own shares from Pfizer3
5,857,582,236
99.90
5,872,298
0.10
5,863,454,534
64.21
418,101,609
 
1 For the purposes of section 341 of the Companies Act 2006, Haleon plc's total issued share capital with voting rights as at 6.30pm on Friday 3 May 2024, being the time at which a shareholder had to be registered in the Company's register of members in order to attend and vote at the AGM, was 9,132,301,104.
2 A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.
3 Pfizer Inc. did not vote any of the ordinary shares held in respect of Resolution 23.
 
As required by the Listing Rule 9.6.2R of the Financial Conduct Authority ("FCA"), copies of resolutions passed by the Company other than resolutions concerning ordinary business have been submitted to the FCA via the National Storage Mechanism and will shortly be available to the public for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
 
 
Amanda Mellor 
Company Secretary 
 
 
About Haleon
Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.
 
For more information, please visit www.haleon.com.  
 
 
 
 
 
 
 
 
 
 
 
 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: May 08, 2024
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary